Our journey in revolutionizing biomedical research
OrganoStemTech was founded from a deep passion for stem cell biology and disease modeling. The goal was to move beyond the limitations of traditional research environments and build a platform capable of delivering innovative, scalable, and accessible technologies to the scientific community.
At its core, OrganoStemTech is driven by the vision of revolutionizing how diseases are studied and how new therapies are developed. By leveraging iPSC technology and advanced 2D and 3D models, we aim to bridge the gap between discovery and application, enabling more accurate, efficient, and ethical research.
What started as a personal scientific ambition has grown into a mission: to help reshape the future of biomedical research and contribute to meaningful advances in human health.
To accelerate the discovery of new drugs, with a future focus on advancing scientific research in the field of Mental Health. We aim to investigate, develop, produce, and provide high-quality, reproducible organoid models—derived from patients or otherwise—with a particular focus on cerebral and intestinal organoids, and future expansion into lung, heart, and multi-organoid systems.
Our goal is to accelerate the discovery of new drugs and personalized therapies and to facilitate their implementation in the market.
We combine cutting-edge stem cell biology with scalable and reproducible differentiation platforms. This enables the generation of highly functional 2D and 3D cellular systems that closely mimic human physiology, providing more predictive and translationally relevant data than conventional models.
From complex organoids to specialized cell types, our products are designed to help partners accelerate research timelines, improve decision-making in preclinical development, and reduce reliance on animal testing.